Back to Results
First PageMeta Content
SLC5A2 / Sodium-glucose transport proteins / Canagliflozin / Diabetes mellitus / Chemistry / Chūō-ku / Osaka / Biology / Health / Daiichi Sankyo / Glycosides / Diabetes


Microsoft Word - 20140704_Approval for CANAGLU_E_Final.doc
Add to Reading List

Document Date: 2014-07-09 23:53:06

Open Document

File Size: 36,65 KB

Share Result on Facebook

City

Tokyo / Osaka / /

Company

Daiichi Sankyo Co. Ltd. / Mitsubishi Tanabe Pharma Corporation / Janssen Pharmaceuticals Inc. / /

Continent

Europe / /

Country

Australia / Japan / United States / Canada / /

MedicalCondition

diabetes mellitus / cardiovascular diseases / diabetes / /

Person

Masayuki Mitsuka / Joji Nakayama / /

/

Position

Representative / Director / CEO / President & Representative / Head Office / Director / President & CEO / /

SocialTag